Semaglutide treatment benefits patients with heart failure and obesity: STEP-HFpEF trial Dr. Kamal Kant Kohli17 Nov 2023 10:45 AM ISTUSA: Obese patients with heart failure with preserved ejection fraction (HFpEF) treated with 2.4 mg semaglutide showed larger reductions in physical...
Analysing changes in patients' voices through an AI-phone app can detect worsening heart failure: Study Dr. Kamal Kant Kohli15 Nov 2023 2:00 AM ISTUSA: The researchers have developed a smartphone app using artificial intelligence technology for detecting changes in the voice of a person with...
Continuation of dapagliflozin beneficial among HF patients with deteriorating kidney function Dr.Niharika Harsha B8 Nov 2023 7:00 PM ISTIn a recent study, researchers have explored the safety and effectiveness of continuing treatment with sodium-glucose cotransporter-2 (SGLT2)...
Heart failure no longer death sentence for cancer survivors Dr. Kamal Kant Kohli1 Nov 2023 10:00 PM ISTCancer patients receiving anthracycline chemotherapy have more than twice the risk of developing heart failure compared to their peers without...
Increasing stress hyperglycemia may worsen HF TO in patients with significant secondary mitral regurgitation Medha Baranwal1 Nov 2023 11:30 AM ISTChina: In patients with significant secondary mitral regurgitation (sMR), increasing stress hyperglycemia ratio (SHR) is tied to a higher risk of...
Exemed Gets CDSCO Panel Nod To study dapagliflozin, Sacubitril, Valsartan as Sodium salt tablet Dr. Divya Colin29 Oct 2023 1:21 PM ISTNew Delhi: Exemed Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
SGLT2 inhibitor ertugliflozin fails to prevent HF hospitalization at EF>60 percent: VERTIS CV analyses Medha Baranwal27 Oct 2023 12:30 PM ISTUSA: Post-hoc analyses of the VERTIS CV trial failed to show the ability of SGLT2 inhibitor ertugliflozin (Steglatro) to reduce hospitalization for...
Adaptive CRT may not reduce HF decompensation or mortality versus conventional CRT among patients with HFrEF and LBBB Medha Baranwal24 Oct 2023 10:45 AM ISTUSA: A randomised controlled trial comparing adaptive versus conventional cardiac resynchronisation therapy (CRT) in patients with heart failure (HF)...
Dapagliflozin safely improves outcomes in people with apparent treatment-resistant hypertension: DELIVER Trial Medha Baranwal16 Oct 2023 11:30 AM ISTUSA: In a post hoc analysis of the DELIVER trial dapagliflozin was shown to be well-tolerated and consistently improved clinical outcomes, including...
Hemodynamic monitoring using PA sensors benefits HF patients with no recent hospitalization: GUIDE-HF analysis Medha Baranwal14 Oct 2023 10:45 AM ISTUSA: Pulmonary artery (PA) pressure monitoring imparts significant clinical and quality-of-life benefits in patients with moderately symptomatic heart...
Medical Bulletin 13/October/2023 Isra Zaman13 Oct 2023 3:30 PM ISTOverviewHere are the top medical news of the day:Treatment-resistant epilepsy: New drug shows promiseMany individuals with focal epilepsy continue to...
Amlodipine : Study Dispels Concerns About the Drug Causing Heart Failure Isra Zaman13 Oct 2023 9:30 AM ISTA new paper published by Oxford University Press, finds that a widely prescribed drug for treating hypertension, amlodipine, is not dangerous for...
